person · Reporting owner

Roush John A

Disclosed activity across 4 companies

Tapewire entity: 1928
SEC CIK: 0001308225

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ADVANCED ENERGY INDUSTRIES INCAEIS · Entity 3497	Director	May 07, 2026	May 08, 2026
LEMAITRE VASCULAR INCLMAT · Entity 1927	Director	September 03, 2026	September 08, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ADVANCED ENERGY INDUSTRIES INC

Report date May 07, 2026 · Filed May 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	587	Reported balance After 2026-05-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-07 · Grant · Acquired 587 · Balance 587 F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F2: Restricted stock units are not exercisable and do not have an expiration date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date.

F2: Restricted stock units are not exercisable and do not have an expiration date.

LEMAITRE VASCULAR INC

Report date September 03, 2026 · Filed September 08, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.6103	Reported balance After 2026-09-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.5195	Reported balance After 2026-09-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.1836	Reported balance After 2026-09-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	5.486	Reported balance After 2026-09-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Dividend Equivalent RightsSEC Table II · derivative / convertible security	Direct	4.2988	Reported balance After 2026-09-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ESS Tech, Inc.

Report date October 08, 2021 · Filed October 13, 2021

Section 16 reporting ended · disclosed 2021-10-13. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

NOVANTA INC

Report date September 01, 2016 · Filed September 06, 2016

Section 16 reporting ended · disclosed 2016-09-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	477,961	Ending reported balance After 2016-09-01 transaction · row 6 6 source rows · reconciled sequence Row 1 · 2016-09-01 · Exercise / conversion · Acquired 15,310 · Balance 473,899 Row 2 · 2016-09-01 · Tax withholding · Disposed 7,204 · Balance 466,695 Row 3 · 2016-09-01 · Exercise / conversion · Acquired 15,186 · Balance 481,881 Row 4 · 2016-09-01 · Tax withholding · Disposed 7,146 · Balance 474,735 Row 5 · 2016-09-01 · Exercise / conversion · Acquired 6,094 · Balance 480,829 Row 6 · 2016-09-01 · Tax withholding · Disposed 2,868 · Balance 477,961
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2016-09-01 · Exercise / conversion · Disposed 15,310 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2016-09-01 · Exercise / conversion · Disposed 15,186 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2016-09-01 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2016-09-01 · Exercise / conversion · Disposed 6,094 · Balance 0 F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit. F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share upon vesting of such Restricted Stock Unit.

F2: Represents the pro-rata vesting of the Reporting Person's outstanding Restricted Stock Units in accordance with the terms of the Transition and Release of Claims Agreement dated July 27, 2016. The Reporting Person's unvested Restricted Stock Units have been forfeited.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 03, 2026 Filed Sep 8, 2026 20:44 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.6637	$0.00	$0.00	Disclosure SEC source: 0001193125-26-385305 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2988 Underlying: Common Stock · 1.6637 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 03, 2026 Filed Sep 8, 2026 20:44 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.0022	$0.00	$0.00	Disclosure SEC source: 0001193125-26-385305 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.486 Underlying: Common Stock · 1.0022 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 03, 2026 Filed Sep 8, 2026 20:44 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8852	$0.00	$0.00	Disclosure SEC source: 0001193125-26-385305 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.1836 Underlying: Common Stock · 0.8852 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 03, 2026 Filed Sep 8, 2026 20:44 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.6503	$0.00	$0.00	Disclosure SEC source: 0001193125-26-385305 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.5195 Underlying: Common Stock · 0.6503 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 03, 2026 Filed Sep 8, 2026 20:44 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.5429	$0.00	$0.00	Disclosure SEC source: 0001193125-26-385305 · ownership.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.6103 Underlying: Common Stock · 0.5429 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:37 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionStock Option (Right to Buy) · Derivative	3,444	$0.00 Strike: $48.60	$0.00	Disclosure SEC source: 0001193125-26-381984 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,444 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:37 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	3,444	$48.60	$167,378.40	Disclosure SEC source: 0001193125-26-381984 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:36 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.4274	$0.00	$0.00	Disclosure SEC source: 0001193125-26-260023 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.6351 Underlying: Common Stock · 1.4274 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:36 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8599	$0.00	$0.00	Disclosure SEC source: 0001193125-26-260023 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.4838 Underlying: Common Stock · 0.8599 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:36 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.7595	$0.00	$0.00	Disclosure SEC source: 0001193125-26-260023 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2984 Underlying: Common Stock · 0.7595 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:36 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.5579	$0.00	$0.00	Disclosure SEC source: 0001193125-26-260023 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.8692 Underlying: Common Stock · 0.5579 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:36 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4658	$0.00	$0.00	Disclosure SEC source: 0001193125-26-260023 · ownership.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.0674 Underlying: Common Stock · 0.4658 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
May 07, 2026 Filed May 8, 2026 16:32 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	GrantRestricted Stock Units · Derivative	587	$0.00	$0.00	Disclosure SEC source: 0001308225-26-000006 · ownership.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587 Underlying: Common Stock · 587 shares Expires not disclosed F1 · derivative.exercise_price: Represents an annual grant of restricted stock units to the reporting person on May 7, 2026 as the equity portion of the non-employee directors' retainer for Board services under the 2023 Amended and Restated Omnibus Incentive Plan. The restricted stock units vest on the one-year anniversary of the grant date contingent upon the reporting person's continued service as director upon such date. F2 · derivative.exercise_date: Restricted stock units are not exercisable and do not have an expiration date. F2 · derivative.expiration_date: Restricted stock units are not exercisable and do not have an expiration date. Read SEC document
May 02, 2026 Filed May 6, 2026 00:36 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionRestricted Stock Units · Derivative	2,313	$0.00	$0.00	Disclosure SEC source: 0001308225-26-000004 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 2, 2025, the reporting person was granted 2,313 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Restricted stock units are not exercisable and do not have an expiration date. F2 · derivative.expiration_date: Restricted stock units are not exercisable and do not have an expiration date. Read SEC document
May 02, 2026 Filed May 6, 2026 00:36 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	Exercise / conversionCommon Stock	2,313	Not disclosed	Not disclosed	Disclosure SEC source: 0001308225-26-000004 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 2, 2025, the reporting person was granted 2,313 restricted stock units, which vested on the one-year anniversary of the grant date. Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:00 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	1.2077	$0.00	$0.00	Disclosure SEC source: 0001193125-26-132280 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.2077 Underlying: Common Stock · 1.2077 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:00 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.7276	$0.00	$0.00	Disclosure SEC source: 0001193125-26-132280 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.6239 Underlying: Common Stock · 0.7276 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:00 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.6426	$0.00	$0.00	Disclosure SEC source: 0001193125-26-132280 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.5389 Underlying: Common Stock · 0.6426 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:00 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.472	$0.00	$0.00	Disclosure SEC source: 0001193125-26-132280 · ownership.xml · derivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.3113 Underlying: Common Stock · 0.472 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 26, 2026 Filed Mar 30, 2026 22:00 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.3941	$0.00	$0.00	Disclosure SEC source: 0001193125-26-132280 · ownership.xml · derivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.6016 Underlying: Common Stock · 0.3941 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	300	$326.75	$98,025.00	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 7 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,593 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. F6 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $326.50 to $327.26, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	2,706	$325.26	$880,153.56	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,893 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. F5 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $324.99 to $325.74, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	3,291	$324.29	$1,067,238.39	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,599 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. F4 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $323.89 to $324.87, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	500	$323.79	$161,895.00	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,890 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	1,728	$322.32	$556,968.96	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,390 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. F3 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $322.10 to $323.00, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	500	$320.76	$160,380.00	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,118 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:16 UTC	ADVANCED ENERGY INDUSTRIES INC AEIS · Entity 3497	SaleCommon Stock	1,200	$319.78	$383,736.00	Disclosure SEC source: 0001308225-26-000002 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,618 F1 · kind: The reported sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2025. F2 · price: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $319.22 to $320.19, inclusive. The reporting person undertakes to provide to the Company, any securityholder of the Company or SEC staff, upon request, full information regarding the number of shares sold at each price within the range specified herein. Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:13 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	1	$0.00	$0.00	Disclosure SEC source: 0001193125-26-086315 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.8963 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:13 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	1	$0.00	$0.00	Disclosure SEC source: 0001193125-26-086315 · ownership.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F2 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
February 26, 2026 Filed Mar 3, 2026 02:13 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantCommon Stock	476	$0.00	$0.00	Disclosure SEC source: 0001193125-26-086315 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,941 F1 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 1/3 upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next two years. Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	5	$0.00	$0.00	Disclosure SEC source: 0001193125-25-319535 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero. Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	5	$0.00	$0.00	Disclosure SEC source: 0001193125-25-319535 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · balance_after: Fractional shares (if any) were settled in cash on each vesting date, resulting in a final balance of zero. Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	5	$0.00	$0.00	Disclosure SEC source: 0001193125-25-319535 · ownership.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 12, 2025 Filed Dec 15, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	5	$0.00	$0.00	Disclosure SEC source: 0001193125-25-319535 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantStock Option (Right to Buy) · Derivative	3,431	$0.00 Strike: $83.66	$0.00	Disclosure SEC source: 0001193125-25-316341 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,431 Underlying: Common Stock · 3,431 shares Expires 2030-12-10 F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years. Read SEC document
December 10, 2025 Filed Dec 11, 2025 23:07 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantCommon Stock	533	$0.00	$0.00	Disclosure SEC source: 0001193125-25-316341 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,455 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years. Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	3	$0.00	$0.00	Disclosure SEC source: 0001193125-25-314618 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8393 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	2	$0.00	$0.00	Disclosure SEC source: 0001193125-25-314618 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4.2075 Underlying: Common Stock · 2 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/8/2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	3	$0.00	$0.00	Disclosure SEC source: 0001193125-25-314618 · ownership.xml · nonDerivative · entry 2 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 08, 2025 Filed Dec 11, 2025 00:26 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	2	$0.00	$0.00	Disclosure SEC source: 0001193125-25-314618 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionDividend Equivalent Rights · Derivative	1	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 8 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.8963 Underlying: Common Stock · 1 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/6/2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 06, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	Exercise / conversionCommon Stock	1	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · nonDerivative · entry 1 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.9869	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 7 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8963 Underlying: Common Stock · 0.9869 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.9702	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 6 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.8393 Underlying: Common Stock · 0.9702 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.81	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.2075 Underlying: Common Stock · 0.81 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4736	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.0005 Underlying: Common Stock · 0.4736 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
December 04, 2025 Filed Dec 9, 2025 01:20 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.4736	$0.00	$0.00	Disclosure SEC source: 0001193125-25-311605 · ownership.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6.9892 Underlying: Common Stock · 0.4736 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:31 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8697	$0.00	$0.00	Disclosure SEC source: 0001437749-25-028587 · rdgdoc.xml · derivative · entry 5 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.9094 Underlying: Common Stock · 0.8697 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:31 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.8546	$0.00	$0.00	Disclosure SEC source: 0001437749-25-028587 · rdgdoc.xml · derivative · entry 4 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.8691 Underlying: Common Stock · 0.8546 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document
September 04, 2025 Filed Sep 8, 2025 22:31 UTC	LEMAITRE VASCULAR INC LMAT · Entity 1927	GrantDividend Equivalent Rights · Derivative	0.7138	$0.00	$0.00	Disclosure SEC source: 0001437749-25-028587 · rdgdoc.xml · derivative · entry 3 Roush John A · CIK 0001308225 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5.3975 Underlying: Common Stock · 0.7138 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.